CASE REPORT | May 3, 2024
Triple-Negative Breast Cancer in a Young 23-Year-Old Woman with BRCA Mutation A about A Case and Literature Review
Ismail Belhaouz, Moad Belouad, Liban Mahdi, Samir Bargach
Page no 214-216 |
DOI: 10.36348/sijog.2024.v07i05.001
Triple-negative breast cancer (estrogen receptor negative, progesterone receptor negative and HER2 negative) is a particularly high-risk breast cancer which does not receive specific therapy targeting these proteins. We report the case of a 23-year-old patient diagnosed with triple-negative breast cancer of the left breast with a family history of breast cancer and carrying a BRCA1 mutation. The classification of breast cancer based on genomic data is required to allow us to optimize therapies and improve the management of breast cancer patients.